Chronic spontaneous urticaria guidelines: What is new?

Urticaria angioedema consensus evidence-based guidelines hives itch mast cell urticaria wheal

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
12 2022
Historique:
received: 08 08 2022
revised: 29 09 2022
accepted: 05 10 2022
entrez: 8 12 2022
pubmed: 9 12 2022
medline: 15 12 2022
Statut: ppublish

Résumé

Urticaria is a heterogeneous inflammatory disorder that can be acute or chronic and is defined by the appearance of wheals, angioedema, or both. Very recently, the newest update and revision of the international European Academy of Allergy and Clinical Immunology/Global Allergy and Asthma European Network/European Dermatology Forum/Asia Pacific Association of Allergy Asthma Clinical Immunology guideline for the definition, classification, diagnosis, and management of urticaria was published. It aims to help primary care physicians and specialists in the management of their patients with urticaria. The guideline applied the Grading of Recommendations Assessment Development and Evaluations approach to developing consensus recommendations. These recommendations were then discussed in a Delphi conference that included more than 250 specialists in the field, and they are endorsed by more than 50 international societies. Here, we highlight changes from previous versions of the international urticaria guideline and their impact on clinical practice.

Identifiants

pubmed: 36481045
pii: S0091-6749(22)01341-0
doi: 10.1016/j.jaci.2022.10.004
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1249-1255

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Torsten Zuberbier (T)

Institute of Allergology, Charité - Universitätsmedizin Berlin; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berli. Electronic address: Torsten.Zuberbier@charite.de.

Jonathan A Bernstein (JA)

University of Cincinnati College of Medicine, Cincinnati.

Marcus Maurer (M)

Institute of Allergology, Charité - Universitätsmedizin Berlin; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berli.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH